Two Sigma Advisers’s Axonics, Inc. Common Stock AXNX Stock Holding History

Two Sigma Advisers’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-136,400	Closed	-$6.88M	–	2619
2023 Q2	$6.88M	Sell	136,400 -94,600	-41%	-$5.03M	0.02%	628
2023 Q1	$12.6M	Sell	231,000 -21,500	-9%	-$1.26M	0.03%	474
2022 Q4	$15.8M	Buy	252,500 +97,200	+63%	+$6.45M	0.04%	399
2022 Q3	$10.9M	Buy	155,300 +145,200	+1,438%	+$10M	0.03%	479
2022 Q2	$572K	Buy	10,100 +2,900	+40%	+$159K	﹤0.01%	1850
2022 Q1	$451K	Buy	+7,200	New	+$388K	﹤0.01%	2038
2021 Q3	–	Sell	-3,600	Closed	-$228K	–	2727
2021 Q2	$228K	Sell	3,600 -37,200	-91%	-$2.2M	﹤0.01%	2236
2021 Q1	$2.44M	Buy	+40,800	New	+$2.22M	0.01%	1174

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Two Sigma Advisers's AXNX Position: Q3 2023 in Review

Two Sigma Advisers sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 136,400 shares — an estimated $6.88M sold.

Two Sigma Advisers first reported a position in AXNX in Q1 2021 and held it in 8 quarters. The position peaked at $15.8M in Q4 2022. 220 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

Two Sigma Advisers reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Advisers sold 136,400 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $6.88M.
Two Sigma Advisers first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Two Sigma Advisers's Axonics, Inc. Common Stock position peaked at $15.8M in Q4 2022.
220 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.